Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimization of Treatment and Management of Schizophrenia in Europe

NCT01248195 is registered in ClinicalTrials.gov with Rene Kahn as lead sponsor.

NCT NCT01248195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01248195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimization of Treatment and Management of Schizophrenia in Europe
Lead sponsor
Rene Kahn
Phase
Phase 4
Overall status
Completed
Start date
May 31, 2011
Completion date
April 30, 2016
Enrollment
479 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

schizoaffective disorder, schizophrenia, schizophreniform disorder